
IndraLab
Statements
Dihydroartemisinin inhibits MYD88. 3 / 3
|
3
reach
"In the PMEC experiment, compared with the control, increased mRNA abundances of Toll like receptor (TLR) -4 downstream target, myeloid differentiation factor 88 (MyD88), IL-6 and IL-8 were observed in LPS treatment, whereas DHA appeared to decrease mRNA abundances of MyD88, IL-6 and IL-8 induced by LPS."